Gebe kadınlarda Toxoplasma, Rubella, Sitomegalovirüs ve Herpes Simpleks Virus Tip 2 serum antikorlarının sıklığı

Abstract

Infections during pregnancy are one of the causes of morbidity and mortality for mother and fetus. TORCH are the microorganisms that cause congenital infections. Prevention and treatment of TORCH infection is very important for maternal and child health. In this study, we aimed to determine the seroprevalence of these infections among pregnant women. Material and Methods: Laboratory data of 1371 pregnant women were evaluated retrospectively. Toxoplasma, Rubella and Cytomegalovirus IgM and IgG antibodies were tested by the carbonylmetalloimmunoassay method. Results: The ages of pregnant women whose laboratory data were examined, varied between 17 and 47, and the mean age was 30.1 ± 5.2. Positive Toxoplasma IgG antibody was found 36.3%, while 1.0% were positive for the Toxoplasma IgM antibody. Rubella IgG seropositivity was found 94.3%, and Rubella IgM was found 0.7%. CMV IgG and IgM positivities were detected in 94.1% and 0.9% respectively. Conclusion: Detection of antenatal risk groups is an important step in the prevention of congenital syndromes. Therefore, it is very important to know the seropositivity rates of that region. The common population screening may contribute to the prevention of congenital infections due to TORCH agents. Toxoplasma gondii screening can be recommended because the prevalence is not high. CMV screening is not significant due to high seroprevalence. High anti-rubella IgG seropositivity shows that pregnant women in this region have high immunity levels.